Artigo Acesso aberto Revisado por pares

Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample

2023; Korean Society of Epidemiology; Volume: 45; Linguagem: Inglês

10.4178/epih.e2023075

ISSN

2092-7193

Autores

Jina Han, Hye Jin Baek, Eunbi Noh, Kyuhyun Yoon, Jung Ae Kim, Sukhyun Ryu, Kay O Lee, No Yai Park, Eunok Jung, Sang-Il Kim, Hyukmin Lee, Yoo-Sung Hwang, Jaehun Jung, Hun Jae Lee, Sung‐Il Cho, Sangcheol Oh, Mi-Gyeong Kim, Chang‐Mo Oh, Byeng-Chul Yu, Young‐Seoub Hong, Keon-Yeop Kim, Sun Jae Jung, Mi Ah Han, Moo‐Sik Lee, Jung-Jeung Lee, Young Hwangbo, Hyeon Woo Yim, Yu‐Mi Kim, Joongyub Lee, Weon‐Young Lee, Jae‐Hyun Park, Sung‐Soo Oh, Heui Sug Jo, Hyeongsu Kim, Gilwon Kang, Hae‐Sung Nam, Ju Hyung Lee, Gyung‐Jae Oh, Min‐Ho Shin, So Yeon Ryu, Tae‐Yoon Hwang, Soon-Woo Park, Sang-Kyu Kim, Roma Seol, Ki‐Soo Park, Su Young Kim, Jun-wook Kwon, Sung Soon Kim, Byoungguk Kim, June-Woo Lee, Eun Young Jang, Ah-Ra Kim, Jeong-Hyun Nam, Soon Young Lee, Dong-Hyun Kim,

Tópico(s)

COVID-19 Clinical Research Studies

Resumo

We estimated the population prevalence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including unreported infections, through a Korea Seroprevalence Study of Monitoring of SARS-CoV-2 Antibody Retention and Transmission (K-SEROSMART) in 258 communities throughout Korea.

Referência(s)